Obagi Medical Products, Inc. (OMPI)

I’ve been watching OMPI for a nice low-risk spot to enter, but it hasn’t happened yet. It has good earnings growth and a nice-looking chart:
OMPI
What also interests me is that insiders own 73% of the company.